Top FDA official in charge of overseeing new COVID-19 vaccines says he’ll resign if agency is pressured into a premature approval. A top US health regulator who will help decide… Read more »
Corporate , Disease , Government , Investment , Pharmaceuticals BioNTech SE , Center for Biologics Evaluation and Research , Coronavirus , COVID-19 , David Campos , H. Clifford Lane , Harmony Biosciences Holdings Inc. , Inhibrx Inc. , Johnson & Johnson , Jonathan Reiner , Journal of the American Medical Association , Kaiser Health News , Kymera Therapeutics Inc. , Michael Caputo , Mike Lindell , Momenta Pharmaceuticals Inc. , Nano-X Imaging Ltd. , National Institutes of Health , Outset Medical Inc. , Peter Marks , Pfizer Inc. , President Donald Trump , Principia Biopharma Inc. , Remdesivir , Sanofi SA , Sputnik V , The National Institute of Allergy and Infectious Diseases , U.S. Food and Drug Administration , Universe Pharmaceuticals Inc.
